Merck’s COVID pill shows lower efficacy in updated study
Drugmaker says final analysis of trial results showed molnupiravir showed 30 percent risk reduction.
source https://www.aljazeera.com/news/2021/11/26/merck-covid-pill-shows-lower-efficacy-in-updated-study
source https://www.aljazeera.com/news/2021/11/26/merck-covid-pill-shows-lower-efficacy-in-updated-study
No comments
Post a Comment